A new DRUG TRIALS SNAPSHOT FOR TAGRISSO is now available. TAGRISSO is a drug used to treat patients with a type of lung cancer called advanced non-small cell lung cancer (NSCLC). It is to be used only in patients whose cancer has a specific mutation of the epidermal growth factor receptor, called T790M, and whose disease has gotten worse after treatment with another specific treatment called EGFR-inhibitor therapy.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.
No hay comentarios:
Publicar un comentario